57961-48-5

Basic information

• Product Name: Benzenebutanoic acid, 3-chloro-.alpha.,.gaMMa.-dioxo-, ethyl est
• Synonyms: Benzenebutanoic acid, 3-chloro-.alpha.,.gaMMa.-dioxo-, ethyl est;3-CHLORO-ALPHA,GAMMA-DIOXO-BENZENEBUTANOIC ACID ETHYL ESTER;Benzenebutanoic acid, 3-chloro-.alpha.,.gaMMa.-dioxo-, ethyl ester;Ethyl 3-chloro-a,g-dioxo-benzenebutanoate
• CAS NO: 57961-48-5
• Molecular Formula: C₁₂H₁₁ClO₄
• Molecular Weight: 254.66634
• Mol File: 57961-48-5.mol
• Article Data: 23

Chemical Properties

• Melting Point: 51-52 °C
• Boiling Point: 391.2±27.0 °C(Predicted)
• Appearance: /
• Density: 1.276±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 6.09±0.46(Predicted)
• CAS DataBase Reference: Benzenebutanoic acid, 3-chloro-.alpha.,.gaMMa.-dioxo-, ethyl est(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenebutanoic acid, 3-chloro-.alpha.,.gaMMa.-dioxo-, ethyl est(57961-48-5)
• EPA Substance Registry System: Benzenebutanoic acid, 3-chloro-.alpha.,.gaMMa.-dioxo-, ethyl est(57961-48-5)

Safety Data

• Hazardous Substances Data: 57961-48-5(Hazardous Substances Data)

Usage

General Description

Benzenebutanoic acid, 3-chloro-.alpha.,.gaMMa.-dioxo-, ethyl est is a chemical compound with the molecular formula C12H9ClO5. It is an ethyl ester of 3-chloro-4,4-dioxo-3-phenylbutanoic acid and is commonly used in various industrial applications. Benzenebutanoic acid, 3-chloro-.alpha.,.gaMMa.-dioxo-, ethyl est is known for its unique chemical properties and is often used as a reagent in organic synthesis and pharmaceutical research. It may also be used in the production of certain pharmaceutical drugs and agrochemicals due to its ability to modify and enhance chemical reactions. Additionally, it has potential applications in the field of material science and may be used as a starting material for the synthesis of various organic compounds.

Upstream product

• 95-92-1 oxalic acid diethyl ester 
• 99-02-5 3'-Chloroacetophenone 
• 587-04-2 m-Chlorobenzaldehyde 
• 120121-01-9 1-(m-Chlorophenyl)ethanol 

Downstream Products

• 478868-71-2 4-(3-Chloro-phenyl)-3-[(Z)-hydroxyimino]-2,4-dioxo-butyric acid ethyl ester 
• 1285545-03-0 ethyl 5-(3-chlorophenyl)-1H-pyrazole-3-carboxylate 
• 595610-50-7 5-(3-chlorophenyl)-1H-pyrazole-3-carboxylic acid 
• 478868-79-0 5-(3-chloro-phenyl)-1-methyl-4-nitroso-1H-pyrazole-3-carboxylic acid ethyl ester 
• 478868-94-9 4-amino-5-(3-chloro-phenyl)-1-methyl-1H-pyrazole-3-carboxylic acid ethyl ester 
• 478869-11-3 3-(3-chloro-phenyl)-2,5-dimethyl-2,6-dihydro-pyrazolo[4,3-d]pyrimidin-7-one 
• 478869-19-1 7-chloro-3-(3-chloro-phenyl)-2,5-dimethyl-2H-pyrazolo[4,3-d]pyrimidine 
• 657424-77-6 ethyl 5-(3-chlorophenyl)isoxazole-3-carboxylate 
• 660417-41-4 5-(3-chloro-phenyl)-isoxazole-3-carboxylic acid methyl ester 
• 1188200-46-5 C₁₂H₉BrClNO₃ 
• 1273029-86-9 C₁₅H₁₄BrClN₂O₂ 
• 657424-79-8 [5-(3-Chloro-phenyl)-isoxazol-3-yl]-methanol 
• 323594-74-7 C₁₀H₇BrClNO 
• 1277100-08-9 C₂₂H₂₂ClN₃O₃*ClH 

Relevant articles and documents

COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS

The invention relates to a compound of Formula I, pharmaceutical compositions comprising a compound of Formula I, and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I to

Design and Synthesis of Novel Arylisoxazole-Chromenone Carboxamides: Investigation of Biological Activities Associated with Alzheimer's Disease

A novel series of hybrid arylisoxazole-chromenone carboxamides were designed, synthesized, and evaluated for their cholinesterase (ChE) inhibitory activity based on the modified Ellman's method. Among synthesized compounds, 5-(3-nitrophenyl)-N-{4-[(2-oxo-

Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators

Antibiotic resistance among clinically significant bacterial pathogens is becoming a prevalent threat to public health, and new antibacterial agents with novel mechanisms of action hence are in an urgent need. Utilizing computational docking method and structure-based optimization strategy, we rationally designed and synthesized two series of isoxazol-3-yl- and isoxazol-5-yl-containing benzamide derivatives that targeted the bacterial cell division protein FtsZ. Evaluation of their activity against a panel of Gram-positive and -negative pathogens revealed that compounds B14 and B16 that possessed the isoxazol-5-yl group showed strong antibacterial activity against various testing strains, including methicillin-resistant Staphylococcus aureus and penicillin-resistant S. aureus. Further molecular biological studies and docking analyses proved that the compound functioned as an effective inhibitor to alter the dynamics of FtsZ self-polymerization via a stimulatory mechanism, which finally terminated the cell division and caused cell death. Taken together, these results could suggest a promising chemotype for development of new FtsZ-targeting bactericidal agent.